3Haibel H,Rudwaleit M,Braun J ,et al. Six months open label trial of leflunomide inactive ankylosing Spondylitis [J]. Ann Rheum Dis, 2005,64(7) : 124-126.
4Braun J ,Bollow M ,Neure L,et al. Use of immunohistologic and is situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosingspondlitis [J]. Arthritis Rheum,1995,38(4):499-505.
6Braun J. Van der Heijde D. Novel approaches in the treatment of ankylosing spongylitis angother spongyloarthritides [J]. Expert Opin Investing Drugs,2003,12(7):1097-1109.
3[1]Khan M.A current perspective on ankylosing spondylitis and related spondyloarthropathies[J].J Ind Rheum Asso,1999,7(1)∶16-22.
4[2]Yu D.Spondyloarthropathies[J].Rheum Dis Clin North Am,1998,24(4)∶663-894.
5[3]Marker-Hermann E,Hohler T.Pathogenesis of HLA-B27 positive arthritis:information from clinical materials[J].Rheum Dis Clin North Am,1998,24(4)∶865-882.
6[4]Ferraz M,Tugwell P,Goldsmith C,et al.Meta-analysis of sulphasalazine in ankylosing spondylitis[J].J Rheumatol,1990,17(11)∶1482-1486.
7[5]Dougados M,van der Linden S,Leirisalo-Repo M,et al.Sulphasalazine in the treatment of ankylosing spondylitis:a randomized, multicentre,double-blind,placebo-controlled study[J].Arthritis Rheum,1995,38(5)∶618-627.
8[6]Sampaio-Burros P,Costallat L,Bertolo M,et al.Methotrexate in the treatment of ankylosing spondylitis[J].Scand J Rheumatol,2000,29(3)∶160-162.
9[7]Creemers M,Franssen M,van der Putte L,et al.Methotrexate in severe ankylosing spondylitis:an open study[J].J Rheumatol,1995,22(6)∶1104-1107.
10[8]Handler R.Favorable results using methotrexate in the treatment of patients with ankylosing spondylitis[J].Arthritis Rheum,1989,32(2)∶234.
1Braun J,Sieper J. Ankylosing spondylitis[J].Lancet,2007.1379-1390.
2Zink A,Braun J,ListingJ,et a1. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis-results from the German rheumatological database[J].Rheumatol,2000.613-622.
